NASDAQ:EKSO Ekso Bionics (EKSO) Stock Price, News & Analysis $0.29 -0.01 (-3.14%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$0.28 -0.01 (-3.14%) As of 05/30/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Ekso Bionics Stock (NASDAQ:EKSO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Ekso Bionics alerts:Sign Up Key Stats Today's Range$0.28▼$0.3050-Day Range$4.40▼$114.4152-Week Range$0.23▼$1.53Volume766,887 shsAverage Volume856,451 shsMarket Capitalization$10.35 millionP/E RatioN/ADividend YieldN/APrice Target$562.50Consensus RatingBuy Company OverviewEkso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.Read More… Ekso Bionics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScoreEKSO MarketRank™: Ekso Bionics scored higher than 63% of companies evaluated by MarketBeat, and ranked 420th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingEkso Bionics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEkso Bionics has only been the subject of 2 research reports in the past 90 days.Read more about Ekso Bionics' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Ekso Bionics are expected to grow in the coming year, from ($0.48) to ($0.15) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ekso Bionics is -0.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Ekso Bionics is -0.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEkso Bionics has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Ekso Bionics' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.98% of the float of Ekso Bionics has been sold short.Short Interest Ratio / Days to CoverEkso Bionics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ekso Bionics has recently decreased by 37.65%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEkso Bionics does not currently pay a dividend.Dividend GrowthEkso Bionics does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.98% of the float of Ekso Bionics has been sold short.Short Interest Ratio / Days to CoverEkso Bionics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ekso Bionics has recently decreased by 37.65%, indicating that investor sentiment is improving significantly. News and Social Media3.1 / 5News Sentiment0.51 News SentimentEkso Bionics has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Ekso Bionics this week, compared to 1 article on an average week.Search Interest3 people have searched for EKSO on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Ekso Bionics to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Ekso Bionics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.10% of the stock of Ekso Bionics is held by insiders.Percentage Held by InstitutionsOnly 6.42% of the stock of Ekso Bionics is held by institutions.Read more about Ekso Bionics' insider trading history. Receive EKSO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter. Email Address EKSO Stock News HeadlinesEkso Bionics trading halted, news pendingMay 31 at 1:30 AM | msn.comEkso Bionics (NASDAQ:EKSO) Shares Scheduled to Reverse Split on Monday, June 2ndMay 25, 2025 | americanbankingnews.comDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profitable miners selling at deep discounts. I call this price gap the Golden Anomaly — and I’ve put together a full report on my top four picks. June 1, 2025 | Golden Portfolio (Ad)Ekso Bionics Stock to Reverse Split on Monday, June 2nd (NASDAQ:EKSO)May 25, 2025 | americanbankingnews.comEkso Bionics sets new date for reverse stock splitMay 23, 2025 | investing.comEkso Bionics Stock to Reverse Split on Tuesday, May 27th (NASDAQ:EKSO)May 23, 2025 | americanbankingnews.comEkso Bionics Holdings, Inc.: Ekso Bionics Announces New Effective Date of Reverse Stock SplitMay 22, 2025 | finanznachrichten.deStockNews.com Begins Coverage on Ekso Bionics (NASDAQ:EKSO)May 22, 2025 | americanbankingnews.comSee More Headlines EKSO Stock Analysis - Frequently Asked Questions How have EKSO shares performed this year? Ekso Bionics' stock was trading at $137.25 on January 1st, 2025. Since then, EKSO shares have decreased by 99.8% and is now trading at $0.2932. View the best growth stocks for 2025 here. How were Ekso Bionics' earnings last quarter? Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) announced its quarterly earnings data on Monday, May, 5th. The company reported ($27.00) earnings per share for the quarter, missing the consensus estimate of ($24.75) by $2.25. The business had revenue of $3.38 million for the quarter, compared to analyst estimates of $4.62 million. Ekso Bionics had a negative trailing twelve-month return on equity of 83.09% and a negative net margin of 62.95%. Read the conference call transcript. When did Ekso Bionics' stock split? Ekso Bionics's stock reverse split on the morning of Tuesday, May 27th 2025. The 1-15 reverse split was announced on Monday, May 19th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 26th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. Who are Ekso Bionics' major shareholders? Ekso Bionics' top institutional investors include Armistice Capital LLC (7.03%) and Cresset Asset Management LLC (0.93%). Insiders that own company stock include Steven Sherman, Scott G Davis, Jerome Wong and Jason C Jones. View institutional ownership trends. How do I buy shares of Ekso Bionics? Shares of EKSO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Ekso Bionics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ekso Bionics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), TransEnterix (TRXDW), Meta Platforms (META), Tesla (TSLA), Editas Medicine (EDIT) and Micron Technology (MU). Company Calendar Last Earnings5/05/2025Today5/31/2025Next Earnings (Estimated)7/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry General industrial machinery, Sub-IndustryMachinery Current SymbolNASDAQ:EKSO Previous SymbolOTCMKTS:EKSOD CIK1549084 Webwww.eksobionics.com Phone(510) 984-1761Fax510-927-2647Employees60Year FoundedN/APrice Target and Rating Average Stock Price Target$562.50 High Stock Price Target$900.00 Low Stock Price Target$225.00 Potential Upside/Downside+191,748.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$15.20 million Net Margins-62.95% Pretax Margin-62.95% Return on Equity-83.09% Return on Assets-39.03% Debt Debt-to-Equity Ratio0.28 Current Ratio2.81 Quick Ratio2.14 Sales & Book Value Annual Sales$17.54 million Price / Sales0.59 Cash FlowN/A Price / Cash FlowN/A Book Value$0.85 per share Price / Book0.34Miscellaneous Outstanding Shares35,290,000Free Float20,656,000Market Cap$10.35 million OptionableOptionable Beta1.09 Social Links 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:EKSO) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind ...Altimetry | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Buffett Indicator is screaming, “sell stocks, buy gold”A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ekso Bionics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ekso Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.